HomeSNNUF • OTCMKTS
add
Smith & Nephew plc
Previous close
$12.92
Year range
$11.49 - $15.70
Market cap
10.98B USD
Avg Volume
481.00
P/E ratio
-
Dividend yield
-
Primary exchange
LON
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 1.41B | 3.40% |
Operating expense | 823.00M | 1.42% |
Net income | 107.00M | 24.42% |
Net profit margin | 7.57 | 20.35% |
Earnings per share | — | — |
EBITDA | 260.00M | -7.31% |
Effective tax rate | 15.41% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 568.00M | 198.95% |
Total assets | 10.54B | 7.09% |
Total liabilities | 5.34B | 15.74% |
Total equity | 5.20B | — |
Shares outstanding | 873.47M | — |
Price to book | 2.17 | — |
Return on assets | 3.89% | — |
Return on capital | 4.63% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 107.00M | 24.42% |
Cash from operations | 119.00M | 110.62% |
Cash from investing | -180.00M | -97.80% |
Cash from financing | 186.00M | 532.56% |
Net change in cash | 122.50M | 252.17% |
Free cash flow | 100.62M | -25.77% |
About
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company headquartered in Watford, England. It is an international producer of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products. Its products are sold in over 100 countries. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index. Wikipedia
CEO
Founded
1856
Website
Employees
18,000
